M. H. Gambarin-gelwan, Clin Liver Dis, vol.11, pp.945-963, 2007.

A. S. Lok, Chronic hepatitis B, N Engl J Med, vol.346, pp.1682-1683, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02507275

P. J. Tsai, A. Chang, S. Yamada, N. Tsai, and M. L. Bartholomew, Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women, Dig Dis Sci, vol.59, pp.2797-2803, 2014.

J. Liu, D. Fan, and C. Hepatitis-b-in, Lancet, vol.369, pp.60723-60728, 2007.

S. Tavakolpour, M. Darvishi, H. S. Mirsafaei, and M. Ghasemiadl, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review, Infect Dis, pp.1-12, 2017.

K. Thiele, L. Diao, P. C. Arck, and . Immunometabolism, Semin Immunopathol, 2017.

G. Mor and I. Cardenas, The immune system in pregnancy: a unique complexity, Am J Reprod Immunol, vol.63, pp.425-433, 2010.

G. L. Euler, K. G. Wooten, A. L. Baughman, and W. W. Williams, Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission, Pediatrics, vol.111, pp.1192-1197, 2003.

G. R. Han, A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection, J Hepatol, vol.55, pp.1215-1221, 2011.

M. K. Celen, Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection, World J Gastroenterol, vol.19, pp.9377-9382, 2013.

G. Jourdain, Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen, BMC Infect Dis, vol.16, 2016.

, European Association For The Study Of The, L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection, J Hepatol, vol.57, pp.167-185, 2012.

D. Ganem and A. M. Prince, Hepatitis B virus infection-natural history and clinical consequences, N Engl J Med, vol.350, pp.1118-1129, 2004.

C. Q. Pan and J. X. Zhang, Natural History and Clinical Consequences of Hepatitis B Virus Infection, Int J Med Sci, vol.2, pp.36-40, 2005.

K. Farmer, T. Gunn, and D. G. Woodfield, A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers, N Z Med J, vol.100, pp.412-414, 1987.

P. M. Grosheide, Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization, Am J Dis Child, vol.147, pp.1316-1320, 1993.

C. Q. Pan, Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load, N Engl J Med, vol.374, pp.2324-2334, 2016.

C. E. Stevens, R. P. Beasley, J. Tsui, and W. C. Lee, Vertical transmission of hepatitis B antigen in Taiwan, N Engl J Med, vol.292, pp.771-774, 1975.

M. Kumar, T. Singh, and S. Sinha, Chronic hepatitis B virus infection and pregnancy, J Clin Exp Hepatol, vol.2, pp.366-381, 2012.

J. Z. Chen, Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load, Sci Rep, vol.7, 2017.

, Care and Treatment of Persons with Chronic Hepatitis B Infection WHO Guidelines Approved by the Guidelines Review Committee, Guidelines for the Prevention, 2015.

H. L. Chen, Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus, Hepatology, vol.62, pp.375-386, 2015.

A. J. Greenup, Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus, J Hepatol, vol.61, pp.502-507, 2014.

G. Samadi-kochaksaraei, Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region, J Viral Hepat, vol.23, pp.15-22, 2016.

Y. H. Hu, M. Liu, W. Yi, Y. J. Cao, and H. D. Cai, Tenofovir rescue therapy in pregnant females with chronic hepatitis B, World J Gastroenterol, vol.21, pp.2504-2509, 2015.

P. Marcellin, Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France, Dig Dis Sci, vol.61, pp.3072-3083, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01812701

C. Q. Pan, Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series, Dig Dis Sci, vol.57, pp.2423-2429, 2012.

J. Wang, Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV, Antivir Ther, vol.20, pp.681-687, 2015.

, Scientific RepoRTs |, vol.8, 2018.

X. Li, Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine-and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients, J Clin Microbiol, vol.48, pp.4363-4369, 2010.

A. Soderstrom, G. Norkrans, and M. Lindh, Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission, Scand J Infect Dis, vol.35, pp.814-819, 2003.

, Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol, vol.67, pp.370-398, 2017.

H. L. Chen, Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV, Gastroenterology, vol.142, pp.773-781, 2012.

W. M. Xu, Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study, J Viral Hepat, vol.16, pp.94-103, 2009.

G. Jourdain, Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B, N Engl J Med, vol.378, pp.911-923, 2018.

R. Del-canho, P. M. Grosheide, S. W. Schalm, R. R. De-vries, and R. A. Heijtink, Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates, J Hepatol, vol.20, pp.483-486, 1994.

E. Wiseman, Perinatal transmission of hepatitis B virus: an Australian experience, Med J Aust, vol.190, pp.489-492, 2009.

L. Zhang, A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission, Eur J Pediatr, vol.173, pp.1161-1168, 2014.

K. K. Van-rompay, Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects, Antimicrob Agents Chemother, vol.52, pp.3144-3160, 2008.

A. Ayres, Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations, J Viral Hepat, vol.21, pp.809-817, 2014.

V. Nguyen, Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare, Aliment Pharmacol Ther, vol.39, pp.1225-1234, 2014.

M. L. Chang and Y. F. Liaw, Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management, J Hepatol, vol.61, pp.1407-1417, 2014.

, Chinese Foundation for Hepatitis, Chinese Society of Infectious Diseases, C. M. A. & Chinese Society of Hepatology, C. M. A

, Zhonghua Gan Zang Bing Za Zhi, vol.25, pp.254-256, 2017.

Y. Liu, Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection, J Viral Hepat, vol.18, pp.29-39, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00850143